What amount sold does Ethos Capital Investments II LP report in Form D filings?

The latest linked filings report $446.9M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Ethos Capital Investments II LP's most recent SEC filing?

Ethos Capital Investments II LP's most recent Form D filing was on 2026-08-24.

How many investors does Ethos Capital Investments II LP have?

The most recent Form D filing lists 43 investor(s).

What type of securities does Ethos Capital Investments II LP offer?

Ethos Capital Investments II LP's SEC Form D filings indicate equity offerings.

Ethos Capital Investments II LP

CIK: 0002067863·Pooled Investment Fund·BOSTON, MA·Limited Partnership·Founded 2025

Reported Sold

$446,937,000

Total Filings

Identified Offerings

Last Filed

Aug 24, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Aug 24, 2026Form D/A — Amendment

Reported sold: $446,937,000 · Target: Indefinite

Rule 506(c)·43 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Exemptions

May 16, 2025Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 506(c)·0 investors·Section 3(c), Section 3(c)(1), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 1 identified offering

$446,937,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

ERIK BROOKS

Related Person

Appears on 1 filing

FADI CHEHADE

Related Person

Appears on 1 filing

BRENT STONE

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 24, 2026	Amendment	Indefinite	$446,937,000	43
May 16, 2025	New	Indefinite	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026